Folate and Vitamin B12 Levels and Mortality in Liver Disease
Author Information
Author(s): Zhu Jiaxin, Liao Xinyi, Du Lei, Lv Pengju, Deng Jian
Primary Institution: Zhengzhou Central Hospital Affiliated to Zhengzhou University
Hypothesis
How do serum folate and vitamin B12 levels affect all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)?
Conclusion
Low serum folate and vitamin B12 levels in patients with MASLD are significantly associated with an elevated risk of all-cause mortality.
Supporting Evidence
- Low serum folate and vitamin B12 levels are linked to higher mortality in patients with MASLD.
- Participants with higher folate and vitamin B12 levels had a significantly lower risk of mortality.
- The study followed participants for over 20 years to assess long-term outcomes.
Takeaway
This study found that having low levels of folate and vitamin B12 can make people with a certain liver disease more likely to die. It's important to keep these vitamin levels healthy.
Methodology
The study used multivariable Cox proportional regression models and restricted cubic spline models to evaluate the association of serum folate and vitamin B12 with all-cause mortality in MASLD patients.
Potential Biases
Potential bias due to the observational nature of the study and reliance on self-reported health data.
Limitations
The study relied on a single measurement of serum folate and vitamin B12, lacked histologic examination data, and could not exclude drug-induced hepatic steatosis.
Participant Demographics
Participants were aged 20-74 years, with a diverse representation of race/ethnicity including non-Hispanic whites, non-Hispanic blacks, and Mexican-Americans.
Statistical Information
P-Value
P<0.001 for folate; P=0.016 for vitamin B12
Confidence Interval
95% CI: 0.39-0.86 for vitamin B12; 95% CI: 0.57-0.91 for folate
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website